— Know what they know.
Not Investment Advice

BCEL NASDAQ

Atreca, Inc.
1W: +0.0% 1M: -4.3% 3M: -47.1% 1Y: -91.8% 3Y: -99.1%
$0.09
Last traded 2024-06-14 — delisted
NASDAQ · Healthcare · Biotechnology · $3.6M mcap · 28M float · 0.617% daily turnover

Balance Sheet Trends

Total Assets
$155M -22.5% ▼
5Y CAGR: +33.8%
Total Liabilities
$77M +69.8% ▲
5Y CAGR: -3.7%
Shareholders Equity
$78M -49.4% ▼
Cash & Investments
$70M -39.8% ▼
5Y CAGR: +18.2%
Total Debt
$64M +0.0% ▲
5Y CAGR: +218.5%
Net Debt
$33M +134.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$115M$158M$61M$95M$31M
Short-Term Investments$0$15M$179M$22M$40M
Cash & ST Investments$115M$173M$240M$117M$70M
Net Receivables$282K$242K$5M$0$4M
Inventory$0-$395K$0-$318K$0
Other Current Assets$2M$4M$5M$5M$4M
Total Current Assets$117M$176M$249M$122M$78M
Property, Plant & Equip.$4M$6M$20M$43M$74M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$11M$2M$31M$1M
Other Non-Current Assets$316K$3M$1M$4M$2M
Total Non-Current Assets$4M$20M$23M$78M$77M
Total Assets$122M$196M$272M$200M$155M
— Liabilities —
Accounts Payable$1M$2M$5M$3M$2M
Short-Term Debt$47K$0$0$0$4M
Deferred Revenue$0$0$800K$0$1M
Other Current Liabilities$3M$6M$12M$14M$11M
Total Current Liabilities$5M$8M$17M$17M$16M
Long-Term Debt$100K$53K$4K$0$60M
Other Non-Current Liab.$6K$763K$13M$28M$0
Total Non-Current Liabilities$106K$816K$13M$28M$60M
Total Liabilities$5M$9M$30M$45M$77M
— Equity —
Common Stock$2K$3K$4K$4K$4K
Retained Earnings-$97M-$164M-$250M-$360M-$457M
Accumulated OCI-$4K$16K$58K-$102K-$266K
Total Stockholders Equity$117M$187M$242M$155M$78M
Total Liabilities & Equity$122M$196M$272M$200M$155M
— Key Metrics —
Total Debt$147K$53K$4K$0$64M
Net Debt-$114M-$158M-$61M-$95M$33M
Total Investments$0$25M$181M$53M$41M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms